By Mecwins
We set the bar high. We innovate in biotechnology. At Mecwins we apply the latest advancements in nanotechnology together with our in-house expertise, to help scientists and physicians reach the unreachable in the diagnostic field: Our technology’s limit of detection is several orders of magnitude more sensitive than the limit achieved in routine clinical practices. Mecwins uses its own technology based on single molecule digital counting to produce ultrahigh sensitive immunoassays for oncology, cardiovascular, inflammatory and infectious diseases. The ultra-high sensitivity plays a key role in the infectious diseases (COVID, HIV, hepatitis, etc..) because it accelerated the diagnosis and it allows discriminating symptomatic from asymptomatic patients.
